Life sciences news
-
Novalis Biotech Acceleration invests in San Francisco-based Modality.AI - technology that ‘self-drives’ neurological and psychiatric assessments
Friday September 3rd 2021
Read more
-
Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands
Thursday July 15th 2021
Read more
-
Biotalys completes its €47.5m initial public offering on Euronext Brussel
Wednesday July 7th 2021
Read more
-
EIB boosts innovative biotech company Univercells with €30 million of European financing to support COVID-19-related projects
Friday July 2nd 2021
Read more
-
Bone Therapeutics secures up to €16 million loan financing from the European Investment Bank to accelerate ongoing clinical and commercial development of innovative orthopedic treatments
Thursday July 1st 2021
Read more
-
Newton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology
Wednesday June 30th 2021
Read more
-
Novalis Biotech closes €25 million Biotech Acceleration Fund
Wednesday June 30th 2021
Read more
-
Biotalys launches its Initial Public Offering on Euronext Brussels
Wednesday June 23rd 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy
Tuesday June 22nd 2021
Read more
-
Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels
Tuesday June 15th 2021
Read more
-
Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics
Monday June 14th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
